Guangzhou Boji Medical & Biotechnological Co Ltd provides contract research organization (CRO) services for the development and production of new drugs and medical devices. Its services include approval of new drugs project and activity screening, pharmaceutical research of active pharmaceutical ingredients (APIs) and preparations, drug evaluation (pharmacodynamics, toxicology), clinical research, contract development and manufacturing organization (CDMO), and the commercialization of technology achievements covering all stages of new drug research and development. Humphries, a subsidiary of Boji Medicals, provides international medical registration consulting services and is involved in professional services such as the US Food and Drug Administration (FDA) registration, declaration, and consultation.

Humphries provides supporting consulting services such as assisting domestic enterprises in developing new medicines overseas, including plant medicines, biological medicines, and chemical medicines; CRO screening, evaluation, tendering, and negotiation; clinical trial monitoring, site audit, telephone, and email communication, test design, test report review, and communication, as well as helping domestic enterprises to introduce overseas pharmaceutical and medical device technology.